Hallucinating Long After the Trip is Over: HPPD – Part 2
Potential causes, risks, and ongoing research for Hallucinogen Persisting Perception Disorder (HPPD).
Other Science
Tackling Trauma with Pharmahuasca and DMT
Psychedelics may hold the key to a novel PTSD treatment.
Psychedelic or Not: Of Mice, 5-HT2A Agonists, and Head Shakes
More than half a century since its development, the head-twitch response assay still plays a prominent role in psychedelic research.
COMPASS Patent Challenge Targets Crystallography Errors
Experts say COMPASS’ analysis overlooked one of the crystal forms present in their sample.
Psychedelics and Substance Use Disorder: 4000 BCE to Present Day
The therapeutic uses of psychedelics were discovered over 6,000 years ago, but recent scientific exploration brings them to the mainstream.
Ibogaine and Cardiac Arrhythmia: The Heart of the Matter
Even at therapeutic doses, ibogaine may cause potentially life-threatening cardiac arrhythmia. Science is beginning to unravel the pharmacological factors that may underlie ibogaine-induced cardiotoxicity.
Psychedelics and Mysticism: The Debate Continues
New perspectives on whether mystical experiences have a place in psychedelic science.
Mystical Encounters, With and Without Drugs
Whatever the brain does on drugs, it may be capable of without them.
Can Psilocybin Assisted Psychotherapy Change Attachment Style?
Shifting from insecure to secure attachments may help rescue patients from pathological mental states.
Finding the Psychedelic Sweet Spot
The relationship between efficacy and potency is a key concept in understanding psychedelic drug pharmacology.